erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Gaillat J [Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis]. 2001 Presse Med pmid:11721486
Goldschmidt N et al. Compound cardiac toxicity of oral erythromycin and verapamil. 2001 Ann Pharmacother pmid:11724091
Maniatis AN et al. Dissemination of clonally unrelated erythromycin- and glycopeptide-resistant Enterococcus faecium isolates in a tertiary Greek hospital. 2001 J. Clin. Microbiol. pmid:11724887
Meyer RD [Legionaire's disease (author's transl)]. 1979 MMW Munch Med Wochenschr pmid:117313
Asai T et al. Pre-operative oral erythromycin reduces residual gastric volume and acidity. 2000 Br J Anaesth pmid:11732520
Kunin CM Letter: Erythromycin in staphylococcal infections. 1975 JAMA pmid:1173378
Espinosa de los Monteros LE et al. Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center. 2001 Pediatr. Infect. Dis. J. pmid:11734748
Syrogiannopoulos GA et al. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. 2001 Pediatr. Infect. Dis. J. pmid:11734765
Brinberg SL et al. [Dependence of erythromycin biosynthesis on the active acidity of the medium]. 1976 Antibiotiki pmid:11737
Nogami K et al. Intravenous low-dose erythromycin administration for infants with feeding intolerance. 2001 Pediatr Int pmid:11737737
Johnson CN et al. In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children. 2001 Int. J. Antimicrob. Agents pmid:11738340
Hayney MS et al. Effect of influenza immunization on CYP3A4 activity. 2001 Vaccine pmid:11738750
Lebel MH and Mehra S Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. 2001 Pediatr. Infect. Dis. J. pmid:11740322
Stocks SM and Thomas CR Viability, strength, and fragmentation of Saccharopolyspora erythraea in submerged fermentation. 2001 Biotechnol. Bioeng. pmid:11745148
Frykman S et al. Precursor-directed production of erythromycin analogs by Saccharopolyspora erythraea. 2001 Biotechnol. Bioeng. pmid:11745157
Ho PL et al. Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone. 2001 Sep-Oct Emerging Infect. Dis. pmid:11747711
Honma Y et al. Enhanced anti-Shigella activity of erythromycin supplemented with sulfadiazine. 2001 FEMS Immunol. Med. Microbiol. pmid:11750221
Benedetti E et al. Treatment of severe pneumonia in kidney transplant recipients. 2001 Nov-Dec Transplant. Proc. pmid:11750552
von Eiff C and Peters G Comparative in vitro activity of ABT-773 and two macrolides against staphylococci. 2002 J. Antimicrob. Chemother. pmid:11751787
Kaul A Erythromycin as a prokinetic agent. 2002 J. Pediatr. Gastroenterol. Nutr. pmid:11753157
Jadcherla SR and Berseth CL Effect of erythromycin on gastroduodenal contractile activity in developing neonates. 2002 J. Pediatr. Gastroenterol. Nutr. pmid:11753158
Costalos C et al. Erythromycin as a prokinetic agent in preterm infants. 2002 J. Pediatr. Gastroenterol. Nutr. pmid:11753159
Rodríguez-Avial C et al. [Susceptibility to penicillin and 13 antimicrobial agents in erythromycin-resistant viridans group streptococci isolated from blood cultures]. 2001 Rev Esp Quimioter pmid:11753449
Lumio J et al. Epidemiology of three cases of severe diphtheria in Finnish patients with low antitoxin antibody levels. 2001 Eur. J. Clin. Microbiol. Infect. Dis. pmid:11757971
Sasaki M et al. Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro. 2001 Mediators Inflamm. pmid:11759110
Aanpreung P and Vajaradul C Clinical use of erythromycin in children with gastrointestinal dysmotility. 2001 J Med Assoc Thai pmid:11759961
Petermann W et al. A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia. 2001 Scand. J. Infect. Dis. pmid:11760164
Gür D et al. Streptococcus pneumoniae penicillin resistance in Turkey. 2001 J Chemother pmid:11760219
Aziz EE et al. Risk factors for the development of Clostridium difficile toxin-associated diarrhoea: a pilot study. 2001 Jun-Jul Pharmacoepidemiol Drug Saf pmid:11760491
Parsons RL et al. The absorption of antibiotics in adult patients with coeliac disease. 1975 J. Antimicrob. Chemother. pmid:1176375
Hardee PG et al. Staphylococcal submandibular lymphadentitis of childhood. 2001 J Ir Dent Assoc pmid:11764643
Bingen E [Microbiology in acute otitis media]. 1998 Rev Prat pmid:11767328
Coventry DR and Dilworth MJ Inhibition of protein synthesis by D-threo-chloramphenicol in the laboratory and nodule forms of Rhizobium lupini. 1975 J. Gen. Microbiol. pmid:1176963
García-Rey C et al. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. 2002 J. Clin. Microbiol. pmid:11773111
Holbrook MA and Menninger JR Erythromycin slows aging of Saccharomyces cerevisiae. 2002 J. Gerontol. A Biol. Sci. Med. Sci. pmid:11773204
Richter SS et al. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. 2002 Clin. Infect. Dis. pmid:11774080
Coyle MB et al. Erythromycin and clindamycin resistance in Corynebacterium diphtheriae from skin lesions. 1979 Antimicrob. Agents Chemother. pmid:117748
Liu J et al. [mRNA expression of basic fibroblast growth factor in the pulmonary tissues from rats repeatedly infected with mycoplasma pneumoniae]. 1999 Zhonghua Jie He He Hu Xi Za Zhi pmid:11775917
Príncipe Rodríguez K and Rodríguez Cintrón W Legionnaires' disease: a rare entity in Puerto Rico? 2001 P R Health Sci J pmid:11776727
Li Y et al. [The effect of erythromycin on NF-kappa B activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats]. 1999 Zhonghua Jie He He Hu Xi Za Zhi pmid:11776779
Xiao W et al. [The imbalance of Th1/Th2 cytokine expression in peripheral blood mononuclear cell from asthmatic patients and the effect of erythromycin on these cytokines]. 2000 Zhonghua Jie He He Hu Xi Za Zhi pmid:11778516
Matsuura B et al. Differential determinants for peptide and non-peptidyl ligand binding to the motilin receptor. Critical role of second extracellular loop for peptide binding and action. 2002 J. Biol. Chem. pmid:11781320
Wilkowske CJ and Hermans PE Actions and uses of antimicrobial agents in the treatment of musculoskeletal infections. 1975 Orthop. Clin. North Am. pmid:1178163
Gan G et al. Intestinal absorption and presystemic elimination of the prokinetic agent, EM574, in the rabbit. 2002 J Pharm Sci pmid:11782911
del Castillo F et al. Penicillin-susceptible and erythromycin-resistant Streptococcus pneumoniae in children with acute mastoiditis. 2001 Eur. J. Clin. Microbiol. Infect. Dis. pmid:11783702
Hertweck M et al. Inhibition of nuclear pre-mRNA splicing by antibiotics in vitro. 2002 Eur. J. Biochem. pmid:11784311
Shibuya Y et al. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum. 2001 Respiration pmid:11786718
Fuchs PC et al. Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards. 2002 Antimicrob. Agents Chemother. pmid:11796348
Nagai K et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. 2002 Antimicrob. Agents Chemother. pmid:11796375
Guerin JM and Leibinger F Why not to use erythromycin in GI motility. 2002 Chest pmid:11796472